$ADTX
Aditxt, Inc. Stock $adtx

$adtx Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000121390022072173 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$185.6K	$323.1K	$0.00
YoY Change	76.71%
Cost Of Revenue	$170.2K	$233.7K
YoY Change	118.22%
Gross Profit	$15.43K	$89.44K
YoY Change	-42.96%
Gross Profit Margin	8.31%	27.68%
Selling, General & Admin	$5.134M	$3.911M	$4.602M
YoY Change	-77.0%	-15.01%	87.06%
% of Gross Profit	33274.34%	4372.79%
Research & Development	$3.081M	$1.571M	$1.472M
YoY Change	81.0%	6.73%	407.43%
% of Gross Profit	19969.15%	1755.95%
Depreciation & Amortization	$159.0K	$126.7K	$126.8K
YoY Change	22.51%	-0.07%
% of Gross Profit	1030.72%	141.7%
Operating Expenses	$8.215M	$5.482M	$6.073M
YoY Change	-65.8%	-9.74%	121.65%
Operating Profit	-$8.200M	-$5.392M	-$6.073M
YoY Change	-65.82%	-11.21%
Interest Expense	$16.88K	-$2.165M	-$1.187M
YoY Change	-128.71%	82.49%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$2.165M	-$3.688M
YoY Change		-41.28%
Pretax Income	-$8.183M	-$7.558M	-$9.761M
YoY Change	-65.98%	-22.57%	256.23%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$8.183M	-$7.558M	-$9.761M
YoY Change	-65.98%	-22.57%	256.23%
Net Earnings / Revenue	-4409.04%	-2338.9%
Basic Earnings Per Share		-$5.27	-$28.08
Diluted Earnings Per Share	-$1.96	-$5.27	-$561.6K
COMMON SHARES
Basic Shares Outstanding	4.161M shares	56.85M shares	347.6K shares
Diluted Shares Outstanding		1.433M shares	347.6K shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.769M	$9.245M	$5.469M
YoY Change	-64.83%	69.03%	-60.14%
Cash & Equivalents	$2.769M	$9.245M	$5.469M
Short-Term Investments
Other Short-Term Assets	$496.9K	$689.4K	$416.1K
YoY Change	7.99%	65.7%	-25.7%
Inventory	$950.1K	$1.442M
Prepaid Expenses	$496.9K	$689.4K
Receivables	$528.0K	$662.8K
Other Receivables	$0.00	$585.4K
Total Short-Term Assets	$4.744M	$12.62M	$12.39M
YoY Change	-49.63%	1.93%	-13.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.319M	$2.249M	$6.222M
YoY Change	2.27%	-63.86%	504.12%
Goodwill
YoY Change
Intangibles	$107.0K
YoY Change
Long-Term Investments	$355.4K	$398.1K	$315.7K
YoY Change	-6.3%	26.12%	426.1%
Other Assets		$347.6K	$422.1K
YoY Change		-17.66%
Total Long-Term Assets	$5.992M	$6.555M	$7.201M
YoY Change	-17.32%	-8.97%	560.66%
TOTAL ASSETS
Total Short-Term Assets	$4.744M	$12.62M	$12.39M
Total Long-Term Assets	$5.992M	$6.555M	$7.201M
Total Assets	$10.74M	$19.18M	$19.59M
YoY Change	-35.58%	-2.08%	27.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.959M	$2.712M	$1.656M
YoY Change	24.31%	63.77%	294.28%
Accrued Expenses	$1.087M	$1.123M	$1.020M
YoY Change	-5.11%	10.13%	208.97%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$80.00K	$0.00
YoY Change
Long-Term Debt Due	$410.0K	$246.7K	$744.3K
YoY Change	-41.47%	-66.85%
Total Short-Term Liabilities	$3.644M	$4.373M	$3.601M
YoY Change	1.01%	21.45%	373.79%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$246.7K
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$1.885M	$2.112M	$2.767M
YoY Change	-31.84%	-23.65%	218.02%
Total Long-Term Liabilities	$1.885M	$2.112M	$3.014M
YoY Change	-34.45%	-29.9%	246.38%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.644M	$4.373M	$3.601M
Total Long-Term Liabilities	$1.885M	$2.112M	$3.014M
Total Liabilities	$5.529M	$6.485M	$6.614M
YoY Change	-14.72%	-1.95%	308.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$95.04M	-$86.83M
YoY Change	41.11%
Common Stock	$4.307K	$3.731K
YoY Change	-90.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$201.6K	$201.6K
YoY Change	0.0%
Treasury Stock Shares	2.017K shares	2.017K shares
Shareholders Equity	$5.206M	$12.69M	$12.97M
YoY Change
Total Liabilities & Shareholders Equity	$10.74M	$19.18M	$19.59M
YoY Change	-35.58%	-2.08%	27.43%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$8.183M	-$7.558M	-$9.761M
YoY Change	-65.98%	-22.57%	256.23%
Depreciation, Depletion And Amortization	$159.0K	$126.7K	$126.8K
YoY Change	22.51%	-0.07%
Cash From Operating Activities	-$6.720M	-$7.818M	-$4.526M
YoY Change	-22.68%	72.75%	23.66%
INVESTING ACTIVITIES
Capital Expenditures	$88.82K	-$4.190K	-$182.3K
YoY Change	-177.19%	-97.7%	13.91%
Acquisitions
YoY Change
Other Investing Activities	$268.5K	$91.62K	-$6.860M
YoY Change	-103.21%	-101.34%
Cash From Investing Activities	$179.7K	$87.44K	-$7.042M
YoY Change	-102.12%	-101.24%	4301.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$10.12M
YoY Change			-45.36%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	64.01K	16.17M	8.427M
YoY Change	-99.67%	91.9%	-51.84%
NET CHANGE
Cash From Operating Activities	-6.720M	-7.818M	-4.526M
Cash From Investing Activities	179.7K	87.44K	-7.042M
Cash From Financing Activities	64.01K	16.17M	8.427M
Net Change In Cash	-6.476M	8.441M	-3.141M
YoY Change	-369.55%	-368.76%	-122.96%
FREE CASH FLOW
Cash From Operating Activities	-$6.720M	-$7.818M	-$4.526M
Capital Expenditures	$88.82K	-$4.190K	-$182.3K
Free Cash Flow	-$6.809M	-$7.814M	-$4.344M
YoY Change	-20.61%	79.9%	24.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39336
	dei	Entity Registrant Name EntityRegistrantName	Aditxt, Inc.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3204328
	dei	Entity Address Address Line1 EntityAddressAddressLine1	737 N. Fifth Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Richmond
	dei	Entity Address State Or Province EntityAddressStateOrProvince	VA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	23219
	dei	City Area Code CityAreaCode	(650)
	dei	Local Phone Number LocalPhoneNumber	870-1200
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	ADTX
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4161129	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9244876	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7872061	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	662810	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	89844	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	689417	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	460102	usd
CY2022Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	585372	usd
CY2021Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	500000	usd
CY2022Q3	us-gaap	Public Utilities Inventory PublicUtilitiesInventory	1442426	usd
CY2021Q4	us-gaap	Public Utilities Inventory PublicUtilitiesInventory	494697	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	12624901	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9416704	usd
CY2022Q3	adtx	Fixed Asset FixedAsset	2248868	usd
CY2021Q4	adtx	Fixed Asset FixedAsset	2267297	usd
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	133750	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	214000	usd
CY2022Q3	adtx	Right Of Use Asset Long Term RightOfUseAssetLongTerm	3426746	usd
CY2021Q4	adtx	Right Of Use Asset Long Term RightOfUseAssetLongTerm	4097117	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	398114	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	379250	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	347555	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	289539	usd
CY2022Q3	us-gaap	Assets Assets	19179934	usd
CY2021Q4	us-gaap	Assets Assets	16663907	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2711991	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1575543	usd
CY2022Q3	adtx	Stock Redemption Payable Related Party StockRedemptionPayableRelatedParty	20000	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	80000	usd
CY2022Q3	adtx	Financing On Fixed Assets FinancingOnFixedAssets	246723	usd
CY2021Q4	adtx	Financing On Fixed Assets FinancingOnFixedAssets	700433	usd
CY2022Q3	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	191515	usd
CY2021Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	186058	usd
CY2022Q3	adtx	Operating Lease Liability Short Term Current OperatingLeaseLiabilityShortTermCurrent	1122869	usd
CY2021Q4	adtx	Operating Lease Liability Short Term Current OperatingLeaseLiabilityShortTermCurrent	1145126	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4373098	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3607160	usd
CY2021Q4	adtx	Financing Of Fixed Asset Long Term FinancingOfFixedAssetLongTerm	110041	usd
CY2022Q3	adtx	Operating Lease Liability Long Term Noncurrent OperatingLeaseLiabilityLongTermNoncurrent	2112362	usd
CY2021Q4	adtx	Operating Lease Liability Long Term Noncurrent OperatingLeaseLiabilityLongTermNoncurrent	2765933	usd
CY2022Q3	us-gaap	Liabilities Liabilities	6485460	usd
CY2021Q4	us-gaap	Liabilities Liabilities	6483134	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3733146	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	890614	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3731129	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	888579	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	3731	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	899	usd
CY2022Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	2017	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2017	shares
CY2022Q3	us-gaap	Treasury Stock Value TreasuryStockValue	201605	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	201605	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	99720486	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	77734288	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-86828138	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67352809	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	12694474	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10180773	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19179934	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16663907	usd
CY2022Q3	us-gaap	Revenues Revenues	323125	usd
	us-gaap	Revenues Revenues	748119	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	233684	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	596613	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	89441	usd
	us-gaap	Gross Profit GrossProfit	151506	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3919618	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4451545	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12332728	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14348375	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1570540	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1471544	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4186842	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3340247	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	-8553	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	150056	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	911988	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	252562	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	5418605	usd
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6073145	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	17431558	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	17941184	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5392164	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6073145	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17280052	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17941184	usd
CY2022Q3	us-gaap	Interest Expense Other InterestExpenseOther	645381	usd
CY2021Q3	us-gaap	Interest Expense Other InterestExpenseOther	38198	usd
	us-gaap	Interest Expense Other InterestExpenseOther	742701	usd
	us-gaap	Interest Expense Other InterestExpenseOther	74587	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	10084	usd
CY2021Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	42838	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	30131	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	43267	usd
	us-gaap	Other Income OtherIncome	58960	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2500970	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2500970	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1530102	usd
CY2021Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1191254	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1533048	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1845358	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2165399	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3687584	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2186658	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4377648	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7557563	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9760729	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19466710	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22318832	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-7557563	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-9760729	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19466710	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22318832	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.27
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-28.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-18.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-73.08
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1433175	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	347610	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1080661	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	305416	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	10180773	usd
CY2022Q1	adtx	Stock Issued During Period Value Stock Option And Warrant Compensation StockIssuedDuringPeriodValueStockOptionAndWarrantCompensation	219885	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	377671	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3719	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-6059141	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	4722907	usd
CY2022Q2	adtx	Stock Issued During Period Value Stock Option And Warrant Compensation StockIssuedDuringPeriodValueStockOptionAndWarrantCompensation	724584	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	309704	usd
CY2022Q2	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1203769	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	250000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-5850006	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1360958	usd
CY2022Q3	adtx	Stock Issued During Period Value Stock Option And Warrant Compensation StockIssuedDuringPeriodValueStockOptionAndWarrantCompensation	338439	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	293119	usd
CY2022Q3	adtx	Sale Of Series B Preferred Shares To Related Party SaleOfSeriesBPreferredSharesToRelatedParty	20000	usd
CY2022Q3	adtx	Redemption Of Series B Preferred Shares To Related Party RedemptionOfSeriesBPreferredSharesToRelatedParty	-20000	usd
CY2022Q3	adtx	Shares Issued As Inducement On Loans SharesIssuedAsInducementOnLoans	146522	usd
CY2022Q3	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	878622	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	96030	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17232555	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-94195000000	usd
CY2022Q3	adtx	Stock Issued During Period Value Stock Splits StockIssuedDuringPeriodValueStockSplits	-13	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-7557563	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	12694474	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11011482	usd
CY2021Q1	adtx	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	3718956	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	51240	usd
CY2021Q1	adtx	Stock Issued During Period Value Issuance Of Shares For Compensation StockIssuedDuringPeriodValueIssuanceOfSharesForCompensation	1112200	usd
CY2021Q1	adtx	Stock Issued During Period Value Stock Option And Warrant Compensation StockIssuedDuringPeriodValueStockOptionAndWarrantCompensation	301462	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1414363	usd
	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding	572966	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	947729	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15672032	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13586869	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1322840	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	231316	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6379667	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	11369829	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	181860	usd
CY2021Q2	adtx	Stock Issued During Period Value Issuance Of Shares For Compensation StockIssuedDuringPeriodValueIssuanceOfSharesForCompensation	331500	usd
CY2021Q2	adtx	Stock Issued During Period Value Stock Option And Warrant Compensation StockIssuedDuringPeriodValueStockOptionAndWarrantCompensation	259070	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6178436	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5963823	usd
CY2021Q3	adtx	Stock Issued During Period Value Stock Option And Warrant Compensation StockIssuedDuringPeriodValueStockOptionAndWarrantCompensation	219885	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5749922	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10120001	usd
CY2021Q3	adtx	Stock Issued During Period Value Issuance Of Shares For Vested Restricted Stock Units StockIssuedDuringPeriodValueIssuanceOfSharesForVestedRestrictedStockUnits	674265	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5164	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-9760729	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	12972331	usd
	us-gaap	Net Income Loss NetIncomeLoss	-19466710	usd
	us-gaap	Net Income Loss NetIncomeLoss	-22318832	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2517121	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3136646	usd
	us-gaap	Depreciation Depreciation	296685	usd
	us-gaap	Depreciation Depreciation	266385	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	80250	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	80030	usd
	adtx	Amortization Of Debt Discount AmortizationOfDebtDiscount	1533048	usd
	adtx	Amortization Of Debt Discount AmortizationOfDebtDiscount	1845358	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2500970	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	229315	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	268430	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	18864	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	243359	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1136448	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	278256	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	900693	usd
	adtx	Ti Allowance Receivable TIAllowanceReceivable	87934	usd
	adtx	Ti Allowance Receivable TIAllowanceReceivable	226738	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	152630	usd
	adtx	Note Receivables And Accrued Interest NoteReceivablesAndAccruedInterest	55454	usd
	adtx	Note Receivables And Accrued Interest NoteReceivablesAndAccruedInterest	6542740	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-421644	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7822801	usd
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	80000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3138888	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5000000	usd
	adtx	Discount On Convertible Note Payable From Offering Costs DiscountOnConvertibleNotePayableFromOfferingCosts	-411887	usd
	adtx	Discount On Convertible Note Payable From Offering Costs DiscountOnConvertibleNotePayableFromOfferingCosts	-526460	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3138888	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	315790	usd
	adtx	Sale Of Preferred Shares To Related Party SaleOfPreferredSharesToRelatedParty	20000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	17232555	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	10120001	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3718956	usd
	us-gaap	Proceeds From Issuance Of Common Limited Partners Units ProceedsFromIssuanceOfCommonLimitedPartnersUnits	1109574	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	563751	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	418428	usd
	adtx	Cash Paid On Extinguishment Of Note Payable CashPaidOnExtinguishmentOfNotePayable	1200000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17466491	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16378279	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1372815	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5031391	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7872061	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10500826	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9244876	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5469435	usd
	us-gaap	Interest Expense InterestExpense	740301	usd
	us-gaap	Interest Expense InterestExpense	15789	usd
	us-gaap	Stock Issued1 StockIssued1	5749922	usd
	adtx	Lease Liability Recognized From Right Of Use Assets LeaseLiabilityRecognizedFromRightOfUseAssets	2806427	usd
	adtx	Original Issuance Discount On Notes Payable OriginalIssuanceDiscountOnNotesPayable	1000000	usd
	adtx	Debt Discount From Warrants Issued With Convertible Note Payable DebtDiscountFromWarrantsIssuedWithConvertibleNotePayable	878622	usd
	adtx	Debt Discount From Warrants Issued With Convertible Note Payable DebtDiscountFromWarrantsIssuedWithConvertibleNotePayable	1322840	usd
	adtx	Debt Discount From Warrant Consideration For Convertible Debt Offering Costs DebtDiscountFromWarrantConsiderationForConvertibleDebtOfferingCosts	231316	usd
	adtx	Debt Discount From Shares Issued As Inducement For Convertible Note Payable DebtDiscountFromSharesIssuedAsInducementForConvertibleNotePayable	174522	usd
	adtx	Liability Recognized For Financed Assets LiabilityRecognizedForFinancedAssets	821862	usd
	adtx	Reduction In Exercise Price Of Warrants ReductionInExercisePriceOfWarrants	102267	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	96030	usd
	adtx	Redemption Of Preferred Shares To Related Party RedemptionOfPreferredSharesToRelatedParty	20000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	8619	usd
CY2021Q4	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	3910000	usd
CY2021Q3	us-gaap	Common Unit Issued CommonUnitIssued	91667	shares
CY2021Q3	adtx	Exercise Price Per Shares ExercisePricePerShares	150
CY2021Q4	us-gaap	Common Unit Issued CommonUnitIssued	56667	shares
CY2021Q4	adtx	Exercise Price Per Shares ExercisePricePerShares	75
CY2021Q4	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	4250000	usd
CY2021Q3	adtx	Purchase Price Per Share PurchasePricePerShare	120
CY2021Q3	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	11000000	usd
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	91667	shares
CY2021Q3	adtx	Debt Instrument Term Description DebtInstrumentTermDescription	The warrants have an exercise price of $126.50 per share and are exercisable for a five-year period commencing six months from the date of issuance.
CY2021Q3	adtx	Warrants Exercise Price WarrantsExercisePrice	75
CY2021Q3	adtx	Purchase Of Common Stock PurchaseOfCommonStock	4584	shares
CY2021Q4	adtx	Net Proceeds NetProceeds	16000000	usd
CY2021Q4	us-gaap	Common Unit Issued CommonUnitIssued	164929	shares
CY2021Q4	adtx	Prefunded Warrants Shares PrefundedWarrantsShares	166572	shares
CY2021Q4	adtx	Warrants Exercise Price WarrantsExercisePrice	57.5
CY2022Q3	adtx	Net Proceeds NetProceeds	18100000	usd
CY2022Q3	us-gaap	Common Unit Issued CommonUnitIssued	1224333	shares
CY2022Q3	adtx	Prefunded Warrants Shares PrefundedWarrantsShares	2109000	shares
CY2022Q3	adtx	Purchase Of Common Stock PurchaseOfCommonStock	3333333	shares
CY2022Q3	adtx	Warrants Exercise Price WarrantsExercisePrice	6
CY2022Q3	adtx	Pre Funded Warrants Exercise Price Per Share PreFundedWarrantsExercisePricePerShare	0.001
	adtx	Net Loss Cash Flow From Operating Activities NetLossCashFlowFromOperatingActivities	19466710	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15672032	usd
CY2022Q3	us-gaap	Cash Cash	9244876	usd
CY2022Q3	us-gaap	Customer Funds CustomerFunds	67300000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	75000000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenue and expense during the reporting period. Actual results could differ from those estimates. Significant estimates underlying the condensed financial statements include the collectability of notes receivable, collectability and reserve on accounts receivable, the reserve on insurance billing, and the fair value of stock options and warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentrations of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company maintains its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation. At times, the Company may have deposits in excess of federally insured limits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	49233	usd
	adtx	Licensing Fee For Patents LicensingFeeForPatents	256589	usd
	adtx	Licensing Fee For Patents LicensingFeeForPatents	76245	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	4186842	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	3340247	usd
	adtx	Warrants Of Stock Options WarrantsOfStockOptions	44712	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	10556	shares
	adtx	Dilutive Earning Shares DilutiveEarningShares	5522224	shares
	adtx	Warrants Of Stock Options WarrantsOfStockOptions	42860	shares
	adtx	Dilutive Earning Shares DilutiveEarningShares	28576	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	205280	shares
CY2021Q3	us-gaap	Other Loans Payable OtherLoansPayable	6500000	usd
CY2021Q3	adtx	Common Stock Yields Percentage CommonStockYieldsPercentage	0.50	pure
CY2021Q4	adtx	Description Of Share Exchange Agreement DescriptionOfShareExchangeAgreement	On December 28, 2021, we entered into a Share Exchange Agreement with Cellvera Global f/k/a AiPharma Global, pursuant to which we (i) will acquire 9.5% of the issued and outstanding equity interests in Cellvera Global in exchange for the issuance of 96,324 shares of our common stock of Aditxt and a cash payment of $250,000, at an initial closing upon the satisfaction or waiver of certain conditions to closing; and (ii) acquire the remaining 90.5% of the issued and outstanding equity interests in Cellvera Global in exchange for the issuance of 798,560 shares of our common stock and a cash payment of $250,000 at a secondary closing upon the satisfaction or waiver of certain conditions to closing.
CY2021Q3	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	6500000	usd
CY2021Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.08	pure
CY2021Q4	adtx	Credit Agreement Amendment Description CreditAgreementAmendmentDescription	On October 18, 2021, the Company entered into the first amendment to the Credit Agreement with Cellvera Global and certain affiliated entities (the “Credit Agreement Amendment”), pursuant to which the Company agreed to increase the amount which Cellvera Global was permitted to borrow under the Credit Agreement by $8.5 million to an aggregate of $15.0 million, of which $6.5 million was outstanding prior to entering the Credit Agreement Amendment. The Company agreed to fund such additional borrowings, as requested by Cellvera Global, by advancing 70% of any amounts received by the Company from the exercise of existing warrants or any other capital raises, including the October Offering.
CY2021	adtx	Advanced Credit Agreement AdvancedCreditAgreement	8000000	usd
CY2021	adtx	Credit Agreement CreditAgreement	14500000	usd
CY2021Q4	us-gaap	Loans Receivable With Variable Rates Of Interest1 LoansReceivableWithVariableRatesOfInterest1	14500000	usd
CY2022Q1	us-gaap	Loans Payable LoansPayable	14500000	usd
CY2022Q2	adtx	Aggregate Amounts AggregateAmounts	30000000	usd
CY2021Q4	adtx	Credit Agreement Description CreditAgreementDescription	the Company entered into a secured credit agreement dated December 10, 2021 (the “Target Company Credit Agreement”) and signed on December 10, 2021 with the Target Company, pursuant to which the Company made a secured loan to the Target Company in the principal amount of $500,000 (the “Target Company Loan”) and agreed to make additional secured loans, as requested by the Target Company and approved by the Company, in an amount not to exceed $4.5 million. The Target Company Loan bears interest at a rate of 8% per annum and mature on December 8, 2022, provided, that the Letter of Intent currently contemplates that the Target Company Loan will be forgivable upon the closing of the acquisition contemplated by the letter of intent. The Target Company Credit Agreement also contains certain covenants that prohibit the Target Company from incurring additional indebtedness, entering into any fundamental transactions, issuing any equity interests subject to certain limited exceptions, or making any dispositions of its property. In connection with the Target Company Credit Agreement, the Company entered into a Security Agreement with the Target Company, pursuant to which the Target Company granted the Company a security interest in all of the Target Company’s assets as security for the Target Company Loan.
CY2022Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	500000	usd
CY2022Q3	us-gaap	Loans Receivable With Fixed Rates Of Interest1 LoansReceivableWithFixedRatesOfInterest1	32438	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2932563	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	683695	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2248868	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2654307	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	387010	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2267297	usd
CY2022Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	99980	usd
CY2021Q3	us-gaap	Depreciation Nonproduction DepreciationNonproduction	99857	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	296684	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	266385	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	321000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	187250	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	133750	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	321000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	107000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	214000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26750	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	26970	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	80250	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	80030	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	9600	shares
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.001
CY2022Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	20000	usd
CY2022Q3	adtx	Preferred Stock Votes PreferredStockVotes	250000000	shares
	adtx	Consideration Cash ConsiderationCash	20000	usd
CY2022Q3	us-gaap	Due To Officers Or Stockholders Current And Noncurrent DueToOfficersOrStockholdersCurrentAndNoncurrent	80000	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0475	pure
CY2022Q2	adtx	Aggregates Amount AggregatesAmount	792000	usd
CY2022Q2	adtx	Gross Proceeds GrossProceeds	550000	usd
CY2022Q2	us-gaap	Fee Income On Acceptances Executed FeeIncomeOnAcceptancesExecuted	16500	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	13500	usd
CY2022Q2	adtx	Installment Due Amount InstallmentDueAmount	28000	usd
CY2022Q3	adtx	Aggregates Amount AggregatesAmount	288000	usd
CY2022Q3	adtx	Gross Proceeds GrossProceeds	200000	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	20000	usd
CY2022Q3	adtx	Installment Due Amount InstallmentDueAmount	14400	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	26667	shares
CY2022Q3	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	1277778	usd
CY2022Q3	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.10	pure
CY2022Q3	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	1150000	usd
CY2022Q3	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	25556	shares
CY2022Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	108517	shares
CY2022Q3	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	555556	usd
CY2022Q3	adtx	Gross Proceeds GrossProceeds	500000	usd
CY2022Q3	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	11112	shares
CY2022Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	47182	shares
CY2022Q3	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	11.78
CY2022Q3	adtx	Class Of Warrant Or Righst Date From Which Warrants Rights Exercisable ClassOfWarrantOrRighstDateFromWhichWarrantsRightsExercisable	P5Y
CY2022Q3	adtx	Standard Time StandardTime	P5Y
CY2022Q3	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	11.78
CY2022Q3	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax	7.5
CY2022Q3	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	555555	usd
CY2022Q3	adtx	Gross Proceeds GrossProceeds	500000	usd
CY2022Q3	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	11112	shares
CY2022Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	74074	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	6
CY2022Q3	us-gaap	Principal Transactions Revenue PrincipalTransactionsRevenue	2388889	usd
CY2022Q3	us-gaap	Payments To Acquire Receivables PaymentsToAcquireReceivables	20000	usd
CY2022Q3	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	238889	usd
CY2022Q3	us-gaap	Income Tax Examination Interest Accrued IncomeTaxExaminationInterestAccrued	119444	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	988381	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	515956	usd
	us-gaap	Lease Cost LeaseCost	988381	usd
	us-gaap	Lease Cost LeaseCost	515956	usd
CY2022Q3	adtx	Right Of Use Assets Long Term RightOfUseAssetsLongTerm	3426746	usd
CY2021Q4	adtx	Right Of Use Assets Long Term RightOfUseAssetsLongTerm	4097117	usd
	adtx	Total Right Of Use Asset TotalRightOfUseAsset	3426746	usd
CY2021	adtx	Total Right Of Use Asset TotalRightOfUseAsset	4097117	usd
CY2022Q3	adtx	Operating Lease Liabilities Short Term OperatingLeaseLiabilitiesShortTerm	1122869	usd
CY2021Q4	adtx	Operating Lease Liabilities Short Term OperatingLeaseLiabilitiesShortTerm	1145126	usd
CY2022Q3	adtx	Operating Lease Liabilities Long Term OperatingLeaseLiabilitiesLongTerm	2112362	usd
CY2021Q4	adtx	Operating Lease Liabilities Long Term OperatingLeaseLiabilitiesLongTerm	2765933	usd
CY2022Q3	adtx	Total Lease Liability TotalLeaseLiability	3235231	usd
CY2021Q4	adtx	Total Lease Liability TotalLeaseLiability	3911059	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	adtx	Stock Based Compensation For Consulting Services StockBasedCompensationForConsultingServices	253719	usd
	adtx	Stock Based Compensation For Consulting Services StockBasedCompensationForConsultingServices	238264	usd
CY2021Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	23272	shares
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3718956	usd
	adtx	Stock Based Compensation StockBasedCompensation	1443700	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	674265	usd
	adtx	Shares Of Common Stock SharesOfCommonStock	96050	shares
	adtx	Shares Of Common Stock Offering SharesOfCommonStockOffering	91667	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	adtx	Preferred Stock Votes PreferredStockVotes	250000000	shares
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	20000	usd
	adtx	Stock Based Compensation StockBasedCompensation	2017	usd
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	60000	shares
CY2021Q1	adtx	Fair Market Value FairMarketValue	1	pure
	adtx	Share Based Payment Remnaining Expenses ShareBasedPaymentRemnainingExpenses	310887	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P0Y10M17D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	616781	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	556817	usd
	adtx	Other Research And Development OtherResearchAndDevelopment	59964	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice	200
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	105049	usd
	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	504699	usd
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	163637
CY2022Q2	adtx	Pursuant Agreement Description PursuantAgreementDescription	Pursuant to the agreement, the Holder has agreed to exercise in cash 179,419 of its Series C Warrants at a reduced exercise price of $7.50 per Share (reduced from $57.50 per share), for gross proceeds to the Company of approximately $1.35 million. As an inducement to such exercise, the Company has agreed to reduce the exercise price of the Holder’s remaining Series C Warrants to purchase up to 49,153 Shares from $57.50 to $12.395 per share, which will be non-exercisable for a period of six months following the closing date. The modification of this exercise price resulted in an increase of $344,158 to the fair value of the Series C Warrants. This modification was an inducement on the transaction and as such was recoded to equity resulting in no net change to additional paid in capital. In addition, the Company issued to the Holder a new warrant to purchase up to 407,991 shares of the Company’s common stock at an exercise price of $12.395 per share, which will be non-exercisable for a period of six months following issuance date and have a term of five and one-half years.
	adtx	Vesting Expense VestingExpense	993462	usd
	adtx	Vesting Expense VestingExpense	674265	usd
	adtx	Other Research And Development OtherResearchAndDevelopment	285558	usd
	us-gaap	Other Expenses OtherExpenses	551684	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1	P0Y6M25D
	adtx	Total Granted TotalGranted	11644	shares
CY2022Q3	adtx	Shares Issued1 SharesIssued1	15513	shares
CY2022Q3	adtx	Shares Issued1 sharesIssued1	15153	shares
	adtx	Sale Of Preferred Shares To Related Party SaleOfPreferredSharesToRelatedParty		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021Q4	adtx	Stock Redemption Payable Related Party StockRedemptionPayableRelatedParty		usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q3	adtx	Financing Of Fixed Asset Long Term FinancingOfFixedAssetLongTerm		usd
CY2021Q3	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues		usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2021Q3	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
CY2022Q3	us-gaap	Other Income OtherIncome		usd
CY2021Q3	us-gaap	Other Income OtherIncome		usd
	us-gaap	Other Income OtherIncome		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	adtx	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants		usd
CY2021Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2021Q3	adtx	Stockissued Duringperiod Down Round StockissuedDuringperiodDownRound		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Increase Decrease In Deposits Outstanding IncreaseDecreaseInDepositsOutstanding		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt		usd
	adtx	Debt Discount From Warrant Consideration For Convertible Debt Offering Costs DebtDiscountFromWarrantConsiderationForConvertibleDebtOfferingCosts		usd
	adtx	Debt Discount From Shares Issued As Inducement For Convertible Note Payable DebtDiscountFromSharesIssuedAsInducementForConvertibleNotePayable		usd
	adtx	Liability Recognized For Financed Assets LiabilityRecognizedForFinancedAssets		usd
	adtx	Reduction In Exercise Price Of Warrants ReductionInExercisePriceOfWarrants		usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
	adtx	Redemption Of Preferred Shares To Related Party RedemptionOfPreferredSharesToRelatedParty		usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1		usd
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Proceeds From Issuance Of Common Limited Partners Units ProceedsFromIssuanceOfCommonLimitedPartnersUnits		usd
	adtx	Cash Paid On Extinguishment Of Note Payable CashPaidOnExtinguishmentOfNotePayable		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	adtx	Lease Liability Recognized From Right Of Use Assets LeaseLiabilityRecognizedFromRightOfUseAssets		usd
	adtx	Original Issuance Discount On Notes Payable OriginalIssuanceDiscountOnNotesPayable		usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001726711

Files In Submission

Name	View Source	Status
0001213900-22-072173-index-headers.html	Edgar Link	pending
0001213900-22-072173-index.html	Edgar Link	pending
0001213900-22-072173.txt	Edgar Link	pending
0001213900-22-072173-xbrl.zip	Edgar Link	pending
adtx-20220930.xsd	Edgar Link	pending
f10q0922ex31-1_aditxtinc.htm	Edgar Link	pending
f10q0922ex31-2_aditxtinc.htm	Edgar Link	pending
f10q0922ex32-1_aditxtinc.htm	Edgar Link	pending
f10q0922_aditxt.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
adtx-20220930_cal.xml	Edgar Link	unprocessable
adtx-20220930_def.xml	Edgar Link	unprocessable
adtx-20220930_pre.xml	Edgar Link	unprocessable
adtx-20220930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0922_aditxt_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ADTX
Aditxt, Inc. Stock $adtx

2022 Q4 Form 10-Q Financial Statement

#000121390022072173 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADTX Aditxt, Inc. Stock $adtx

2022 Q4 Form 10-Q Financial Statement

#000121390022072173 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ADTX
Aditxt, Inc. Stock $adtx